MedTrace Logo

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

NCT03727009 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 409

Last updated 2021-02-03

No results posted yet for this study

Summary

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.

Conditions

  • Hematologic Malignancy

Interventions

OTHER

Blood Sample Collection

Subjects participating in the study will have blood drawn at enrollment.

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-07
Primary Completion
2020-03-24
Completion
2020-03-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727009 on ClinicalTrials.gov